LIP
EW icon

Lighthouse Investment Partners’s Edwards Lifesciences EW Stock Holding History

Lighthouse Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$2.1M – 546
2024
Q3 		$2.1M Buy
+30,000
New +$2.18M 0.08% 249

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Lighthouse Investment Partners's EW Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 3,148 shares — an estimated $252K sold.

Lighthouse Investment Partners first reported a position in EW in Q4 2023 and held it in 7 quarters. The position peaked at $9.93M in Q2 2024. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Lighthouse Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 3,148 Edwards Lifesciences shares in Q2 2026, an estimated $252K.
  • Lighthouse Investment Partners first reported a position in Edwards Lifesciences in Q4 2023 and held it in 7 quarters.
  • Lighthouse Investment Partners's Edwards Lifesciences position peaked at $9.93M in Q2 2024.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.